FDA Approves Unknown Drug — CENTAUR PHARMS PVT
# FDA Approves New Generic Drug Application for Centaur Pharmaceuticals The FDA has approved ANDA220470 for Centaur Pharmaceuticals PVT, expanding the company's portfolio and pote…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves New Generic Drug Application for Centaur Pharmaceuticals The FDA has approved ANDA220470 for Centaur Pharmaceuticals PVT, expanding the company's portfolio and pote…
# FDA Approves Brivaracetam Injection Generic, Expanding Market Competition PAI Pharma has received FDA approval for its generic brivaracetam injection, an intravenous formulation…
# FDA Approves Generic Brivaracetam Oral Solution by Florida Pharmaceutical Products Florida Pharmaceutical Products, LLC has received FDA approval for a generic version of brivar…
Zhejiang Poly Pharm Co., Ltd. secured FDA approval for its generic oral formulation of Brivaracetam, granting the manufacturer a competitive foothold in the neurological market and…
# FDA Approves ANDA Application for INVAGEN PHARMS InvaGen Pharmaceuticals has received FDA approval for ANDA218768, expanding its generic drug portfolio and positioning the compa…
# FDA Approves Vanda Pharmaceuticals' New Drug Application The FDA has approved NDA 220358 for Vanda Pharmaceuticals Inc., potentially expanding the company's product portfolio an…
# FDA Approves Avyxa Pharma's FAVLYXA (Fluorouracil) for Intravenous Use The FDA has approved Avyxa Pharma's FAVLYXA (fluorouracil) for intravenous administration, marking the com…
# FDA Approves AVET Lifesciences Generic Drug Application AVET Lifesciences has received FDA approval for ANDA203276, marking the company's entry into an additional generic drug m…
# FDA Approves Colchicine Generic From Micro Labs Limited Micro Labs Limited received FDA approval for its generic colchicine oral formulation, expanding the competitive landscape…
# FDA Approves Janssen's RYBREVANT FASPRO Subcutaneous Formulation The FDA has approved Janssen Biotech's RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj), a subcutaneous for…
# FDA Approves Zydus Lifesciences Generic Drug Application Zydus Lifesciences has received FDA approval for ANDA217815, expanding the company's generic drug portfolio and position…
# FDA Approves Generic Glatiramer Acetate for Ajenat Pharmaceuticals Ajenat Pharmaceuticals LLC has received FDA approval for its generic glatiramer acetate injection (ANDA213382)…
# FDA Approves Encube Ethicals' Generic Tretinoin Topical Formulation The U.S. Food and Drug Administration has approved Encube Ethicals, Inc.'s abbreviated new drug application f…
On February 10, 2026, Hikma announced regulatory approval for a generic drug through ANDA205057, signaling a strategic precedent for future portfolio initiatives despite the absenc…
# FDA Approves Gland Pharma's Generic Zoledronic Acid Gland Pharma Limited has received FDA approval for its generic zoledronic acid intravenous formulation, expanding the competi…
# FDA Approves Generic Carbidopa, Levodopa and Entacapone from Alembic Pharmaceuticals Alembic Pharmaceuticals Inc. received FDA approval for a generic version of carbidopa, levod…
# FDA Approves CIPLA's Generic Drug Application Cipla Limited received FDA approval for its abbreviated new drug application (ANDA 213165) on February 2, 2026, positioning the com…
# FDA Approves Somerset Therapeutics' Generic Rilpivirine Somerset Therapeutics, LLC has received FDA approval for its generic rilpivirine hydrochloride oral formulation (ANDA2187…
# FDA Approves Generic Difluprednate Ophthalmic from Alembic Pharmaceuticals The FDA has approved Alembic Pharmaceuticals' generic difluprednate ophthalmic formulation, expanding …
Novitium Pharma secured FDA approval for its ANDA 219119, a milestone anticipated to accelerate revenue generation and strengthen the company's competitive market position.